8
landing page
Center for Public Health Advisory Board
Paul Chew
President, 1Rx DigiPharm Advisory, LLC
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
A Global Early Warning System for Pandemics: A Blueprint for Coordination
The COVID-19 pandemic has had enormous health, social, and economic consequences.
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
article
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Possible Solutions Webinar Summary
Antimicrobial resistance (AMR) poses a threat to everyone. However, some patients with chronic illne
sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.
+ Read More
article
2023-2026 National Health Security Strategy (NHSS) Comment Letter
Submitted electronically
Ms. Dawn O’Connell
Assistant Secretary for Preparedness and Response
HHS O
ffice of the Assistant Secretary for Preparedness and Response (ASPR)
200 Independence Ave.
Washington, DC 20201
+ Read More